Compare BBNX & VET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBNX | VET |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2025 | N/A |
| Metric | BBNX | VET |
|---|---|---|
| Price | $29.73 | $8.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $28.09 | N/A |
| AVG Volume (30 Days) | 672.2K | ★ 1.4M |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 4.22% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $88,570,000.00 | ★ $1,445,514,003.00 |
| Revenue This Year | $52.13 | $9.23 |
| Revenue Next Year | $36.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 67.01 | 30.48 |
| 52 Week Low | $8.89 | $5.14 |
| 52 Week High | $32.71 | $10.49 |
| Indicator | BBNX | VET |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 44.17 |
| Support Level | $28.00 | $8.54 |
| Resistance Level | $30.50 | $9.28 |
| Average True Range (ATR) | 1.82 | 0.36 |
| MACD | -0.26 | -0.10 |
| Stochastic Oscillator | 38.33 | 10.43 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.